{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:29:36Z","timestamp":1765700976309,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.humpath.2020.09.012","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T14:21:15Z","timestamp":1601302875000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma"],"prefix":"10.1016","volume":"106","author":[{"given":"Wenchang","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1468-8796","authenticated-orcid":false,"given":"Whayoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-7729","authenticated-orcid":false,"given":"Yunxia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal S.","family":"Chandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.09.012_bib1","series-title":"WHO classification of tumors of the digestive system","article-title":"Carcinoma of the gallbladder","author":"Roa","year":"2019"},{"key":"10.1016\/j.humpath.2020.09.012_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrc1429","article-title":"Gallbladder cancer: lessons from a rare tumour","volume":"4","author":"Wistuba","year":"2004","journal-title":"Nat Rev Canc"},{"key":"10.1016\/j.humpath.2020.09.012_bib3","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.humpath.2020.09.012_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.humpath.2020.09.012_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","article-title":"Epidemiology of gallbladder disease: cholelithiasis and cancer","volume":"6","author":"Stinton","year":"2012","journal-title":"Gut Liver"},{"key":"10.1016\/j.humpath.2020.09.012_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jso.2930280311","article-title":"Carcinoma of the gallbladder: autopsy findings in 287 cases and review of the literature","volume":"28","author":"Sons","year":"1985","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.humpath.2020.09.012_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/intimm\/dxr029","article-title":"An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation","volume":"23","author":"Yagi","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.humpath.2020.09.012_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":"Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2020.09.012_bib9","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1101\/gad.1115203","article-title":"GATA-3: an unexpected regulator of cell lineage determination in skin","volume":"17","author":"Kaufman","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2020.09.012_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1309\/AJCP8H2VBDSCIOBF","article-title":"Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas","volume":"142","author":"Clark","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/PAI.0000000000000764","article-title":"Incidence and significance of GATA3 positivity in pancreatic ductal adenocarcinoma and cholangiocarcinoma","volume":"28","author":"Agostini-Vulaj","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2020.09.012_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0959-437X(02)00319-2","article-title":"The GATA family (vertebrates and invertebrates)","volume":"12","author":"Patient","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.humpath.2020.09.012_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/PAP.0b013e3182a28a68","article-title":"Value of GATA3 immunostaining in tumor diagnosis: a review","volume":"20","author":"Ordonez","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.pas.0000213438.01278.5f","article-title":"Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray","volume":"31","author":"Higgins","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncy.21393","article-title":"GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens","volume":"122","author":"Shield","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PAP.0000000000000256","article-title":"An algorithmic immunohistochemical approach to define tumor type and assign site of origin","volume":"27","author":"Bellizzi","year":"2020","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2020.09.012_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAI.0000000000000076","article-title":"Immunohistochemical profile of breast cancer with respect to estrogen receptor and HER2 status","volume":"23","author":"Gloyeske","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2020.09.012_bib20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/PAI.0000000000000237","article-title":"Comparative sensitivities and specificities of antibodies to breast markers GCDFP-15, mammaglobin A, and different clones of antibodies to GATA-3: a study of 338 tumors using whole sections","volume":"24","author":"Kandalaft","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2020.09.012_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.critrevonc.2008.09.005","article-title":"Carcinoma of unknown primary (CUP)","volume":"69","author":"Pavlidis","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.humpath.2020.09.012_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1634\/theoncologist.12-4-418","article-title":"Cancer of unknown primary site: missing primary or missing biology?","volume":"12","author":"Pentheroudakis","year":"2007","journal-title":"Oncol"},{"key":"10.1016\/j.humpath.2020.09.012_bib23","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.ejca.2007.06.023","article-title":"Switching benchmarks in cancer of unknown primary: from autopsy to microarray","volume":"43","author":"Pentheroudakis","year":"2007","journal-title":"Eur J Canc"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:28Z","timestamp":1758645448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":23,"alternative-id":["S0046817720301842"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.09.012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and significance of GATA3 positivity in gallbladder adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}